Hemofarm a.d.
Hemofarm a.d. (full legal name: Hemofarm a.d. Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian pharmaceutical company based in Vršac, Serbia. Founded in 1960, it is one of the largest domestic producer and exporter of medicines in Serbia. Hemofarm currently operates in more than 30 countries on 3 continents and has around 3,000 employees.
Official logo | |
Native name | Хемофарм |
|---|---|
| Company type | Joint-stock company |
| Industry | Pharmaceuticals |
| Founded | 28 August 1998 (current form) 1960 (founded) |
| Headquarters | Beogradski put bb, Vršac , Serbia |
Key people | Ronald Seeliger (CEO) |
| Products | Pharmaceuticals, Prescription drugs |
| Revenue | €337.37 million (2018) |
Net income | €26.47 million (2018) |
| Total assets | €436.09 million (2018) |
| Total equity | €296.34 million (2018) |
| Owner | STADA (100%) |
Number of employees | 3,134 (2018) |
| Website | www |
The core activity represents the manufacture of Rx and OTC medicines and products. The portfolio includes over 140 INNs, with about 280 forms and dosage forms.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.